Skip to main content

Table 3 Characteristics of people not recently tested for HCV RNA by registration type (NSW DBS Pilot September 2019a- December 2020)

From: Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

Variables

Total people tested for HCV in pilot

No HCV test in last two years

Factors associated with no HCV test in last two years

N

n

%

cOR

aOR

Total

4112

1851

45%

  

Registration pathway

 Online self-registration

240

177

74%

3.58 (2.65–4.84)

 

 Assisted registration—community

1815

798

44%

1

 

 Assisted registration—prison

2057

876

43%

0.95 (0.83–1.07)

 

Test performed

 HIV + HCV

3581

1675

47%

  

 HCV only

531

176

33%

  

Gender

 Male

3150

1433

45%

1

 

 Female

918

394

43%

0.90 (0.78–1.04)

 

 Other

44

24

55%

1.44 (0.79–2.61)

 

Age

 = < 25

495

245

49%

1

1

 25–34

1192

500

42%

0.74 (0.60–0.91)

0.76 (0.61–0.94)

 35–44

1212

466

38%

0.64 (0.52–0.79)

0.73 (0.58–0.90)

 45–54

806

400

50%

1.01 (0.80–1.26)

1.20 (0.95–1.52)

 > 55

407

240

59%

1.47 (1.13–1.91)

1.47 (1.12–1.93)

Aboriginal and/or Torres Strait Islander

 No

2755

1333

48%

1

1

 Yes

1357

518

38%

0.66 (0.58–0.75)

0.76 (0.66–0.88)

Men who have sex with men

 No

3824

1701

44%

1

1

 Yes

288

150

52%

1.36 (1.07–1.72)

1.28 (1.00–1.65)

Born outside of Australia

 No

3430

1439

42%

1

 

 Yes, Asia or Africa

284

185

65%

2.59 (2.01–3.33)

 

 Yes, other

398

227

57%

1.84 (1.49–2.27)

 

Speaks English at home

 No

337

210

62%

2.15 (1.71–2.71)

1.59 (1.25–2.02)

 Yes

3775

1641

43%

1

1

Recently injected drugs

 No

2406

1233

51%

1

1

 Yes

1481

474

32%

0.45 (0.39–0.51)

0.46 (0.40–0.53)

 Prefer not to say

225

144

64%

1.69 (1.27–2.25)

1.74 (1.30–2.32)

  1. Proportions are row proportions
  2. Acronyms: HCV hepatitis C virus, cOR crude Odds Ratio, aOR adjusted Odds Ratio
  3. aQuestion on HCV testing recency was introduced in September 2019